These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 9134272)

  • 1. Coronary risk factors, endothelial function, and atherosclerosis: a review.
    Vogel RA
    Clin Cardiol; 1997 May; 20(5):426-32. PubMed ID: 9134272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerosis-associated endothelial dysfunction.
    Schächinger V; Zeiher AM
    Z Kardiol; 2000; 89 Suppl 9():IX/70-4. PubMed ID: 11151799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options.
    Britten MB; Zeiher AM; Schächinger V
    J Intern Med; 1999 Apr; 245(4):315-27. PubMed ID: 10356593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol lowering and endothelial function.
    Vogel RA
    Am J Med; 1999 Nov; 107(5):479-87. PubMed ID: 10569303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension.
    Zeiher AM; Drexler H; Saurbier B; Just H
    J Clin Invest; 1993 Aug; 92(2):652-62. PubMed ID: 8349804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol, cholesterol lowering, and endothelial function.
    Vogel RA; Corretti MC; Gellman J
    Prog Cardiovasc Dis; 1998; 41(2):117-36. PubMed ID: 9790413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium-dependent and -independent functions are impaired in patients with coronary heart disease.
    Zhang X; Zhao SP; Li XP; Gao M; Zhou QC
    Atherosclerosis; 2000 Mar; 149(1):19-24. PubMed ID: 10704610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis.
    Adams MR; Robinson J; McCredie R; Seale JP; Sorensen KE; Deanfield JE; Celermajer DS
    J Am Coll Cardiol; 1998 Jul; 32(1):123-7. PubMed ID: 9669259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lipid-lowering therapy in multiple risk factor management.
    Esper RJ
    Drugs; 1998; 56 Suppl 1():1-7; discussion 33. PubMed ID: 9740535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic mechanisms of atherosclerosis: effect of lipid lowering on the biology of atherosclerosis.
    Ganz P; Creager MA; Fang JC; McConnell MV; Lee RT; Libby P; Selwyn AP
    Am J Med; 1996 Oct; 101(4A):4A10S-16S. PubMed ID: 8900332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease.
    Egashira K
    Circ J; 2002 Jun; 66(6):529-33. PubMed ID: 12074266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial.
    Dupuis J; Tardif JC; Cernacek P; Théroux P
    Circulation; 1999 Jun; 99(25):3227-33. PubMed ID: 10385495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endothelial dysfunction in coronary artery disease and implications for therapy.
    Kinlay S; Ganz P
    Am J Cardiol; 1997 Nov; 80(9A):11I-16I. PubMed ID: 9375937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma soluble adhesion molecules and endothelium-dependent vasodilation in early human atherosclerosis.
    John S; Jacobi J; Delles C; Schlaich MP; Alter O; Schmieder RE
    Clin Sci (Lond); 2000 May; 98(5):521-9. PubMed ID: 10781382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercholesterolemia increases coronary endothelial dysfunction, lipid content, and accelerated atherosclerosis after heart transplantation.
    Perrault LP; Mahlberg F; Breugnot C; Bidouard JP; Villeneuve N; Vilaine JP; Vanhoutte PM
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):728-36. PubMed ID: 10712398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The cellular and molecular-genetic aspects of endothelial dysfunction].
    Shliakhto EV; Berkovich OA; Moiseeva OM
    Vestn Ross Akad Med Nauk; 2004; (10):50-2. PubMed ID: 15575403
    [No Abstract]   [Full Text] [Related]  

  • 20. Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis.
    Tiefenbacher CP; Bleeke T; Vahl C; Amann K; Vogt A; Kübler W
    Circulation; 2000 Oct; 102(18):2172-9. PubMed ID: 11056088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.